Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Invesco Ltd.NYSE: IVZ
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $511.2M rose 52.5% year over year, ahead of the -119.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 42.9% from the prior quarter.
Context
- EBITDA amounted to 6.1% of revenue in FY2025, down 14.4 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $2.04B (+622.2%) for the fiscal year ending Dec 2026, a step up from the -131.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $511.2M+42.9% QoQ
- Last fiscal yearDec 2025
- -$390.8M-131.4% YoY
- LTMJun 2026
- -$256.6M-119.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +52.5% | +25.0% | -27.5 pp |
| 1 year | -131.4% | +622.2% | +753.6 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (390.8M) USD
- Year-over-year change
- -131.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (390.8M) | -131.4% |
| FY2024 | 2024-12-31 | 1.24B | +7970.8% |
| FY2023 | 2023-12-31 | 15.4M | -99.0% |
| FY2022 | 2022-12-31 | 1.53B | -45.4% |
| FY2021 | 2021-12-31 | 2.8B | — |
EBITDA vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 EBITDA of -$256.6M is the lowest of the 11 companies compared; the peer median is $1.31B.
- Its year-over-year change of -119.6% is the lowest of 11, against a peer median of +12.3%.
- EBITDA amounts to 3.7% of revenue for IVZ, versus a peer median of 37.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.5B | +26.2% | +5.3% | 27.8% | |
| LTM Jun 2026 | $3.1B | +7.4% | -1.0% | 40.9% | |
| LTM Jun 2026 | $2.72B | +77.2% | -35.7% | 17.3% | |
| LTM Jun 2026 | $1.75B | +55.2% | -14.9% | 18.7% | |
| LTM Sep 2026 | $1.64B | +38.3% | -8.2% | 63.2% | |
| LTM Sep 2026 | $977.22M | +5.4% | +17.0% | 38.5% | |
| LTM Sep 2026 | $484.41M | +2.4% | +14.1% | 38.5% | |
| LTM Jun 2026 | $343.43M | -51.1% | +2.9% | 100.0% | |
| LTM Mar 2026 | $12.4M | +17.2% | +43.3% | 12.5% | |
| LTM Mar 2026 | $12M | -21.6% | +10.2% | 36.4% | |
| LTM Jun 2026 | -$256.6M | -119.6% | — | 3.7% | |
| Peer median (excluding IVZ) | $1.31B | +12.3% | +4.1% | 37.4% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.89B | 6.05B | 5.72B | 6.07B | 6.38B |
| Cost of Revenue | 4.06B | 3.61B | 3.71B | 4.04B | 3.62B |
| Gross Profit | 2.83B | 2.44B | 2.01B | 2.03B | 2.75B |
| Gross Margin | 41.1% | 40.3% | 35.1% | 33.4% | 43.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 522.7M | 588.2M | 649.7M | 676M | 660.5M |
| Operating Expenses | 1.05B | 1.12B | 2.44B | 1.2B | 3.45B |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| EBITDA | 2.8B | 1.53B | 15.4M | 1.24B | (390.8M) |
| EBITDA Margin | 40.6% | 25.3% | 0.3% | 20.5% | -6.1% |
| Operating Income | 1.79B | 1.32B | (434.8M) | 832.1M | (695.7M) |
| Operating Margin | 25.9% | 21.8% | -7.6% | 13.7% | -10.9% |
| Interest Income | 25.2M | 24.4M | 47.8M | 58.9M | 53.9M |
| Interest Expense | 94.7M | 85.2M | 70.5M | 58M | 82.5M |
| Other Income / Expenses | 712.3M | (70M) | 196.9M | 173.2M | 316.3M |
| Income Before Tax | 2.5B | 1.25B | (237.9M) | 1.01B | (379.4M) |
| Pre-Tax Margin | 36.3% | 20.6% | -4.2% | 16.6% | -5.9% |
| Income Tax Expense | 531.1M | 322.2M | (69.7M) | 252.9M | (204.6M) |
| Net Income | 1.63B | 920.7M | (96.9M) | 774.8M | (281.7M) |
| Net Margin | 23.6% | 15.2% | -1.7% | 12.8% | -4.4% |
| EPS (Basic) | 3.01 | 1.50 | (0.73) | 1.18 | (1.61) |
| EPS (Diluted) | 2.99 | 1.49 | (0.73) | 1.18 | (1.60) |
| Weighted Avg Shares | 462.8M | 457.5M | 454.8M | 457M | 451.2M |
| Weighted Avg Shares (Diluted) | 465.4M | 459.5M | 456.2M | 457.7M | 453.8M |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.